Back to search
Chemotherapy-Induced Myelosuppression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-Induced Myelosuppression trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chemotherapy-Induced Myelosuppression trials you may qualify forThis is a multicenter, randomized, double-blind, placebo-controlled study to assess whether trilaciclib administered prior to topotecan is non-inferior to place…
The purpose of the study is to explore the safety and efficacy of UCMSC-Exo in consolidation chemotherapy-induced myelosuppression in patients with acute myeloi…
This is a Phase 2, multicenter, randomized, open-label study evaluating the safety and efficacy of trilaciclib administered with platinum-based chemotherapy fol…
This prospective, single-arm, exploratory, phase II study was designed to evaluate the efficacy and safety of Trilaciclib in reducing chemotherapy-induced neutr…